United Therapeutics Corporation Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
United Therapeutics Corporation (UTHR) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of $6.80 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2026-02-25
- 2025-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $6.80M.
- 2024-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $12.40M.
- 2023-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $17.90M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $21.70M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax |
|---|---|
| 2025-12-31 | $6.80M 10-K · filed 2026-02-25 |
| 2024-12-31 | $12.40M 10-K · filed 2026-02-25 |
| 2023-12-31 | $17.90M 10-K · filed 2026-02-25 |
| 2022-12-31 | $21.70M 10-K · filed 2025-02-26 |
| 2021-12-31 | $2.00M 10-K · filed 2024-02-21 |
| 2020-12-31 | -$3.80M 10-K · filed 2023-02-22 |
| 2019-12-31 | $4.50M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |